Antineoplastics, Newer
PDL Reference Documents
Drug Use Review Documents
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
NDC | Brand Name | Generic Name | Form | Strength | PDL Status |
Rebate | Current Drug Use Criteria |
---|---|---|---|---|---|---|---|
00002481554 | VERZENIO | abemaciclib | TABLET | 100 mg | Y | PA Document | |
00002533754 | VERZENIO | abemaciclib | TABLET | 150 mg | Y | PA Document | |
00002621654 | VERZENIO | abemaciclib | TABLET | 200 mg | Y | PA Document | |
00002448354 | VERZENIO | abemaciclib | TABLET | 50 mg | Y | PA Document | |
47335040181 | YONSA | abiraterone acet,submicronized | TABLET | 125 mg | Y | PA Document | |
00143959721 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
00378692078 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
00904694804 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
16714096301 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
43598035804 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
60219116507 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
60505432701 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
60687079011 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
60687079021 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
64980041812 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
68001048907 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
68462013508 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
69238116507 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
71921017820 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
72205003092 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
72205028492 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
72603011001 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
75907022404 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
82009013912 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
82249001012 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
82293000110 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
82249001112 | ABIRTEGA | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
57894015012 | ZYTIGA | abiraterone acetate | TABLET | 250 mg | Y | PA Document | |
00378692191 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
43598046860 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
60219175406 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
60505476406 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
68001067306 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
68462088260 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
69238175406 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
71921017706 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
72205028560 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
72603011101 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
72606057301 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
82009014060 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
82293000210 | ABIRATERONE ACETATE | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
57894019506 | ZYTIGA | abiraterone acetate | TABLET | 500 mg | Y | PA Document | |
00310351260 | CALQUENCE | acalabrutinib maleate | TABLET | 100 mg | Y | PA Document | |
00310451360 | CALQUENCE | acalabrutinib maleate | TABLET | 100 mg | Y | PA Document | |
80739081218 | KRAZATI | adagrasib | TABLET | 200 mg | Y | PA Document | |
50242008801 | KADCYLA | ado-trastuzumab emtansine | VIAL | 100 mg | Y | PA Document | |
50242008701 | KADCYLA | ado-trastuzumab emtansine | VIAL | 160 mg | Y | PA Document | |
83205000102 | TECELRA | afamitresgene autoleucel | PLAST. BAG | 2.68 x 10exp9 to 10 x 10exp9 cell | Y | PA Document | |
00597014130 | GILOTRIF | afatinib dimaleate | TABLET | 20 mg | Y | PA Document | |
00597013730 | GILOTRIF | afatinib dimaleate | TABLET | 30 mg | Y | PA Document | |
00597013830 | GILOTRIF | afatinib dimaleate | TABLET | 40 mg | Y | PA Document | |
50242013001 | ALECENSA | alectinib HCl | CAPSULE | 150 mg | Y | PA Document | |
00078070151 | PIQRAY | alpelisib | TABLET | 200 mg/day (200 mg x 1) | Y | PA Document | |
00078070184 | PIQRAY | alpelisib | TABLET | 200 mg/day (200 mg x 1) | Y | PA Document | |
00078071502 | PIQRAY | alpelisib | TABLET | 250 mg/day (200 mg x 1 and 50 mg x 1) | Y | PA Document | |
00078071561 | PIQRAY | alpelisib | TABLET | 250 mg/day (200 mg x 1 and 50 mg x 1) | Y | PA Document | |
00078071591 | PIQRAY | alpelisib | TABLET | 250 mg/day (200 mg x 1 and 50 mg x 1) | Y | PA Document | |
00078071594 | PIQRAY | alpelisib | TABLET | 250 mg/day (200 mg x 1 and 50 mg x 1) | Y | PA Document | |
00078070802 | PIQRAY | alpelisib | TABLET | 300 mg/day (150 mg x 2) | Y | PA Document | |
00078070851 | PIQRAY | alpelisib | TABLET | 300 mg/day (150 mg x 2) | Y | PA Document | |
00078070890 | PIQRAY | alpelisib | TABLET | 300 mg/day (150 mg x 2) | Y | PA Document | |
00078070891 | PIQRAY | alpelisib | TABLET | 300 mg/day (150 mg x 2) | Y | PA Document | |
57894050100 | RYBREVANT | amivantamab-vmjw | VIAL | 350 mg/7 mL (50 mg/mL) | Y | PA Document | |
57894050101 | RYBREVANT | amivantamab-vmjw | VIAL | 350 mg/7 mL (50 mg/mL) | Y | PA Document | |
59676060430 | ERLEADA | apalutamide | TABLET | 240 mg | Y | PA Document | |
59676060012 | ERLEADA | apalutamide | TABLET | 60 mg | Y | PA Document | |
00078119620 | SCEMBLIX | asciminib hydrochloride | TABLET | 100 mg | Y | PA Document | |
00078109120 | SCEMBLIX | asciminib hydrochloride | TABLET | 20 mg | Y | PA Document | |
00078109820 | SCEMBLIX | asciminib hydrochloride | TABLET | 40 mg | Y | PA Document | |
68727090001 | RYLAZE | asparaginase Erwinia-rywn | VIAL | 10 mg/0.5 mL | Y | PA Document | |
68727090003 | RYLAZE | asparaginase Erwinia-rywn | VIAL | 10 mg/0.5 mL | Y | PA Document | |
50242091701 | TECENTRIQ | atezolizumab | VIAL | 1,200 mg/20 mL (60 mg/mL) | Y | PA Document | |
50242091801 | TECENTRIQ | atezolizumab | VIAL | 840 mg/14 mL (60 mg/mL) | Y | PA Document | |
50242093301 | TECENTRIQ HYBREZA | atezolizumab-hyaluronidas-tqjs | VIAL | 1,875 mg-30,000 unit/15 mL | Y | PA Document | |
72064011030 | AYVAKIT | avapritinib | TABLET | 100 mg | Y | PA Document | |
72064012030 | AYVAKIT | avapritinib | TABLET | 200 mg | Y | PA Document | |
72064012530 | AYVAKIT | avapritinib | TABLET | 25 mg | Y | PA Document | |
72064013030 | AYVAKIT | avapritinib | TABLET | 300 mg | Y | PA Document | |
72064015030 | AYVAKIT | avapritinib | TABLET | 50 mg | Y | PA Document | |
44087353501 | BAVENCIO | avelumab | VIAL | 200 mg/10 mL (20 mg/mL) | Y | PA Document | |
71779066002 | AVMAPKI | avutometinib potassium | CAPSULE | 0.8 mg | Y | PA Document | |
71779062301 | AVMAPKI-FAKZYNJA | avutometinib/defactinib | COMBO. PKG | 0.8 mg-200 mg | Y | PA Document | |
71287011901 | YESCARTA | axicabtagene ciloleucel | PLAST. BAG | Y | PA Document | ||
71287011902 | YESCARTA | axicabtagene ciloleucel | PLAST. BAG | Y | PA Document | ||
00069014501 | INLYTA | axitinib | TABLET | 1 mg | Y | PA Document | |
00069015111 | INLYTA | axitinib | TABLET | 5 mg | Y | PA Document | |
59572073007 | ONUREG | azacitidine | TABLET | 200 mg | Y | PA Document | |
59572074007 | ONUREG | azacitidine | TABLET | 300 mg | Y | PA Document | |
72893000201 | BELEODAQ | belinostat | VIAL | 500 mg | Y | PA Document | |
00006533101 | WELIREG | belzutifan | TABLET | 40 mg | Y | PA Document | |
16729025105 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 100 mg | Y | PA Document | |
55150039201 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 100 mg | Y | PA Document | |
60505609600 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 100 mg | Y | PA Document | |
68001057241 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 100 mg | Y | PA Document | |
71288010320 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 100 mg | Y | PA Document | |
63459039120 | TREANDA | bendamustine HCl | VIAL | 100 mg | Y | PA Document | |
16729025003 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg | Y | PA Document | |
55150039101 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg | Y | PA Document | |
60505609500 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg | Y | PA Document | |
68001057141 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg | Y | PA Document | |
71288010210 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg | Y | PA Document | |
63459039008 | TREANDA | bendamustine HCl | VIAL | 25 mg | Y | PA Document | |
42367052125 | BELRAPZO | bendamustine HCl | VIAL | 25 mg/mL | Y | PA Document | |
10019007901 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg/mL | Y | PA Document | |
60505622800 | BENDAMUSTINE HCL | bendamustine HCl | VIAL | 25 mg/mL | Y | PA Document | |
63459034804 | BENDEKA | bendamustine HCl | VIAL | 25 mg/mL | Y | PA Document | |
24338027001 | VIVIMUSTA | bendamustine HCl | VIAL | 25 mg/mL | Y | PA Document | |
71225012001 | VIVIMUSTA | bendamustine HCl | VIAL | 25 mg/mL | Y | PA Document | |
70255001002 | MEKTOVI | binimetinib | TABLET | 15 mg | Y | PA Document | |
55513016001 | BLINCYTO | blinatumomab | KIT | 35 mcg | Y | PA Document | |
55513015001 | BLINCYTO | blinatumomab | VIAL | 35 mcg | Y | PA Document | |
00069101415 | BOSULIF | bosutinib | CAPSULE | 100 mg | Y | PA Document | |
00069050430 | BOSULIF | bosutinib | CAPSULE | 50 mg | Y | PA Document | |
00069013501 | BOSULIF | bosutinib | TABLET | 100 mg | Y | PA Document | |
00069019301 | BOSULIF | bosutinib | TABLET | 400 mg | Y | PA Document | |
00069013601 | BOSULIF | bosutinib | TABLET | 500 mg | Y | PA Document | |
51144005001 | ADCETRIS | brentuximab vedotin | VIAL | 50 mg | Y | PA Document | |
71287022001 | TECARTUS | brexucabtagene autoleucel | PLAST. BAG | 1 x 10exp6 to 1 x 10exp8 cell | Y | PA Document | |
71287022002 | TECARTUS | brexucabtagene autoleucel | PLAST. BAG | 1 x 10exp6 to 1 x 10exp8 cell | Y | PA Document | |
71287021901 | TECARTUS | brexucabtagene autoleucel | PLAST. BAG | 2 x 10exp6 to 2 x 10exp8 cell | Y | PA Document | |
71287021902 | TECARTUS | brexucabtagene autoleucel | PLAST. BAG | 2 x 10exp6 to 2 x 10exp8 cell | Y | PA Document | |
63020019830 | ALUNBRIG | brigatinib | TAB DS PK | 90 mg (7)-180 mg (23) | Y | PA Document | |
63020018023 | ALUNBRIG | brigatinib | TABLET | 180 mg | Y | PA Document | |
63020018030 | ALUNBRIG | brigatinib | TABLET | 180 mg | Y | PA Document | |
63020011330 | ALUNBRIG | brigatinib | TABLET | 30 mg | Y | PA Document | |
63020009007 | ALUNBRIG | brigatinib | TABLET | 90 mg | Y | PA Document | |
63020009030 | ALUNBRIG | brigatinib | TABLET | 90 mg | Y | PA Document | |
00024582315 | JEVTANA | cabazitaxel | VIAL | 10 mg/mL (first dilution) | Y | PA Document | |
00024582411 | JEVTANA | cabazitaxel | VIAL | 10 mg/mL (first dilution) | Y | PA Document | |
42388001214 | COMETRIQ | cabozantinib s-malate | CAPSULE | 100 mg/day (80 mg x 1-20 mg x 1/day) | Y | PA Document | |
42388001114 | COMETRIQ | cabozantinib s-malate | CAPSULE | 140 mg/day (80 mg x 1-20 mg x 3/day) | Y | PA Document | |
42388001314 | COMETRIQ | cabozantinib s-malate | CAPSULE | 60 mg/day (20 mg x 3/day) | Y | PA Document | |
42388002426 | CABOMETYX | cabozantinib s-malate | TABLET | 20 mg | Y | PA Document | |
42388002446 | CABOMETYX | cabozantinib s-malate | TABLET | 20 mg | Y | PA Document | |
42388002526 | CABOMETYX | cabozantinib s-malate | TABLET | 40 mg | Y | PA Document | |
42388002546 | CABOMETYX | cabozantinib s-malate | TABLET | 40 mg | Y | PA Document | |
42388002326 | CABOMETYX | cabozantinib s-malate | TABLET | 60 mg | Y | PA Document | |
42388002336 | CABOMETYX | cabozantinib s-malate | TABLET | 60 mg | Y | PA Document | |
42388002346 | CABOMETYX | cabozantinib s-malate | TABLET | 60 mg | Y | PA Document | |
72694051501 | ASPARLAS | calaspargase pegol-mknl | VIAL | 3,750 unit/5 mL (750 unit/mL) | Y | PA Document | |
00310950001 | TRUQAP | capivasertib | TABLET | 160 mg | Y | PA Document | |
00310950002 | TRUQAP | capivasertib | TABLET | 160 mg | Y | PA Document | |
00310950101 | TRUQAP | capivasertib | TABLET | 200 mg | Y | PA Document | |
00310950102 | TRUQAP | capivasertib | TABLET | 200 mg | Y | PA Document | |
00078070956 | TABRECTA | capmatinib hydrochloride | TABLET | 150 mg | Y | PA Document | |
00078071656 | TABRECTA | capmatinib hydrochloride | TABLET | 200 mg | Y | PA Document | |
76075010301 | KYPROLIS | carfilzomib | VIAL | 10 mg | Y | PA Document | |
76075010201 | KYPROLIS | carfilzomib | VIAL | 30 mg | Y | PA Document | |
76075010101 | KYPROLIS | carfilzomib | VIAL | 60 mg | Y | PA Document | |
61755000801 | LIBTAYO | cemiplimab-rwlc | VIAL | 350 mg/7 mL (50 mg/mL) | Y | PA Document | |
00078069484 | ZYKADIA | ceritinib | TABLET | 150 mg | Y | PA Document | |
57894011101 | CARVYKTI | ciltacabtagene autoleucel | PLAST. BAG | 0.5 x 10exp6 to 1 x 10exp8 cell | Y | PA Document | |
57894011102 | CARVYKTI | ciltacabtagene autoleucel | PLAST. BAG | 0.5 x 10exp6 to 1 x 10exp8 cell | Y | PA Document | |
50242071701 | COTELLIC | cobimetinib fumarate | TABLET | 20 mg | Y | PA Document | |
00069814120 | XALKORI | crizotinib | CAPSULE | 200 mg | Y | PA Document | |
00069814020 | XALKORI | crizotinib | CAPSULE | 250 mg | Y | PA Document | |
00069150060 | XALKORI | crizotinib | PEL DSP CP | 150 mg | Y | PA Document | |
00069025160 | XALKORI | crizotinib | PEL DSP CP | 20 mg | Y | PA Document | |
00069050760 | XALKORI | crizotinib | PEL DSP CP | 50 mg | Y | PA Document | |
00078068266 | TAFINLAR | dabrafenib mesylate | CAPSULE | 50 mg | Y | PA Document | |
00078068166 | TAFINLAR | dabrafenib mesylate | CAPSULE | 75 mg | Y | PA Document | |
00078115421 | TAFINLAR | dabrafenib mesylate | TAB SUSP | 10 mg | Y | PA Document | |
00069019730 | VIZIMPRO | dacomitinib | TABLET | 15 mg | Y | PA Document | |
00069119830 | VIZIMPRO | dacomitinib | TABLET | 30 mg | Y | PA Document | |
00069229930 | VIZIMPRO | dacomitinib | TABLET | 45 mg | Y | PA Document | |
57894050505 | DARZALEX | daratumumab | VIAL | 100 mg/5 mL (20 mg/mL) | Y | PA Document | |
57894050520 | DARZALEX | daratumumab | VIAL | 400 mg/20 mL (20 mg/mL) | Y | PA Document | |
57894050301 | DARZALEX FASPRO | daratumumab-hyaluronidase-fihj | VIAL | 1,800 mg-30,000 unit/15 mL | Y | PA Document | |
50419039501 | NUBEQA | darolutamide | TABLET | 300 mg | Y | PA Document | |
65597080101 | DATROWAY | datopotamab deruxtecan-dlnk | VIAL | 100 mg | Y | PA Document | |
64842072709 | INQOVI | decitabine/cedazuridine | TABLET | 35 mg-100 mg | Y | PA Document | |
71779063001 | FAKZYNJA | defactinib hydrochloride | TABLET | 200 mg | Y | PA Document | |
55566840200 | FIRMAGON | degarelix acetate | VIAL | 120 mg | Y | PA Document | |
55566840301 | FIRMAGON | degarelix acetate | VIAL | 120 mg | Y | PA Document | |
55566830301 | FIRMAGON | degarelix acetate | VIAL | 80 mg | Y | PA Document | |
66302001401 | UNITUXIN | dinutuximab | VIAL | 3.5 mg/mL | Y | PA Document | |
68727025001 | MODEYSO | dordaviprone HCl | CAPSULE | 125 mg | Y | PA Document | |
00173089803 | JEMPERLI | dostarlimab-gxly | VIAL | 500 mg/10 mL (50 mg/mL) | Y | PA Document | |
00310450012 | IMFINZI | durvalumab | VIAL | 120 mg/2.4 mL (50 mg/mL) | Y | PA Document | |
00310461150 | IMFINZI | durvalumab | VIAL | 500 mg/10 mL (50 mg/mL) | Y | PA Document | |
73116021528 | COPIKTRA | duvelisib | CAPSULE | 15 mg | Y | PA Document | |
73116021556 | COPIKTRA | duvelisib | CAPSULE | 15 mg | Y | PA Document | |
73116022528 | COPIKTRA | duvelisib | CAPSULE | 25 mg | Y | PA Document | |
73116022556 | COPIKTRA | duvelisib | CAPSULE | 25 mg | Y | PA Document | |
78670015001 | IWILFIN | eflornithine HCl | TABLET | 192 mg | Y | PA Document | |
72187010203 | ORSERDU | elacestrant HCl | TABLET | 345 mg | Y | PA Document | |
72187010103 | ORSERDU | elacestrant HCl | TABLET | 86 mg | Y | PA Document | |
00003229111 | EMPLICITI | elotuzumab | VIAL | 300 mg | Y | PA Document | |
00003452211 | EMPLICITI | elotuzumab | VIAL | 400 mg | Y | PA Document | |
00069252201 | ELREXFIO | elranatamab-bcmm | VIAL | 44 mg/1.1 mL (40 mg/mL) | Y | PA Document | |
00069252202 | ELREXFIO | elranatamab-bcmm | VIAL | 44 mg/1.1 mL (40 mg/mL) | Y | PA Document | |
00069449401 | ELREXFIO | elranatamab-bcmm | VIAL | 76 mg/1.9 mL (40 mg/mL) | Y | PA Document | |
00069449402 | ELREXFIO | elranatamab-bcmm | VIAL | 76 mg/1.9 mL (40 mg/mL) | Y | PA Document | |
59572071030 | IDHIFA | enasidenib mesylate | TABLET | 100 mg | Y | PA Document | |
59572070530 | IDHIFA | enasidenib mesylate | TABLET | 50 mg | Y | PA Document | |
70255002501 | BRAFTOVI | encorafenib | CAPSULE | 75 mg | Y | PA Document | |
70255002502 | BRAFTOVI | encorafenib | CAPSULE | 75 mg | Y | PA Document | |
70255002503 | BRAFTOVI | encorafenib | CAPSULE | 75 mg | Y | PA Document | |
70255002504 | BRAFTOVI | encorafenib | CAPSULE | 75 mg | Y | PA Document | |
51144002001 | PADCEV | enfortumab vedotin-ejfv | VIAL | 20 mg | Y | PA Document | |
51144003001 | PADCEV | enfortumab vedotin-ejfv | VIAL | 30 mg | Y | PA Document | |
50242009130 | ROZLYTREK | entrectinib | CAPSULE | 100 mg | Y | PA Document | |
50242009490 | ROZLYTREK | entrectinib | CAPSULE | 200 mg | Y | PA Document | |
50242062301 | ROZLYTREK | entrectinib | PELET PACK | 50 mg | Y | PA Document | |
50242062342 | ROZLYTREK | entrectinib | PELET PACK | 50 mg | Y | PA Document | |
00469012599 | XTANDI | enzalutamide | CAPSULE | 40 mg | Y | PA Document | |
00469062599 | XTANDI | enzalutamide | TABLET | 40 mg | Y | PA Document | |
00469072560 | XTANDI | enzalutamide | TABLET | 80 mg | Y | PA Document | |
82705000201 | EPKINLY | epcoritamab-bysp | VIAL | 4 mg/0.8 mL | Y | PA Document | |
82705001001 | EPKINLY | epcoritamab-bysp | VIAL | 48 mg/0.8 mL | Y | PA Document | |
59676003056 | BALVERSA | erdafitinib | TABLET | 3 mg | Y | PA Document | |
59676003084 | BALVERSA | erdafitinib | TABLET | 3 mg | Y | PA Document | |
59676004028 | BALVERSA | erdafitinib | TABLET | 4 mg | Y | PA Document | |
59676004056 | BALVERSA | erdafitinib | TABLET | 4 mg | Y | PA Document | |
59676005028 | BALVERSA | erdafitinib | TABLET | 5 mg | Y | PA Document | |
00143916701 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
00781339194 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
10019008001 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
60505628900 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
68001065641 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
70095008001 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
81298389001 | ERIBULIN MESYLATE | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
62856038901 | HALAVEN | eribulin mesylate | VIAL | 1 mg/2 mL (0.5 mg/mL) | Y | PA Document | |
00078062651 | AFINITOR DISPERZ | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
00078062661 | AFINITOR DISPERZ | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
00378000532 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
00378000585 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
51991099028 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
51991099077 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
51991099099 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
60219227901 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
60219227902 | EVEROLIMUS | everolimus | TAB SUSP | 2 mg | Y | PA Document | |
00078062751 | AFINITOR DISPERZ | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
00078062761 | AFINITOR DISPERZ | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
00378000632 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
00378000685 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
51991099128 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
51991099177 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
51991099199 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
60219228001 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
60219228002 | EVEROLIMUS | everolimus | TAB SUSP | 3 mg | Y | PA Document | |
00078062851 | AFINITOR DISPERZ | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
00078062861 | AFINITOR DISPERZ | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
00378000732 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
00378000785 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
51991099228 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
51991099277 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
51991099299 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
60219228101 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
60219228102 | EVEROLIMUS | everolimus | TAB SUSP | 5 mg | Y | PA Document | |
00054047021 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
49884015802 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
49884015852 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
51991037906 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
51991037960 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
51991037999 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
67877071831 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
67877071833 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
70377006911 | EVEROLIMUS | everolimus | TABLET | 0.25 mg | Y | Y | |
00054047121 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
49884015902 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
49884015952 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
51991038006 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
51991038060 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
51991038099 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
67877071931 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
67877071933 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
70377007011 | EVEROLIMUS | everolimus | TABLET | 0.5 mg | Y | Y | |
00054047221 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
49884016002 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
49884016052 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
51991038106 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
51991038160 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
51991038199 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
67877072031 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
67877072033 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
70377007111 | EVEROLIMUS | everolimus | TABLET | 0.75 mg | Y | Y | |
00054060421 | EVEROLIMUS | everolimus | TABLET | 1 mg | Y | Y | |
49884028302 | EVEROLIMUS | everolimus | TABLET | 1 mg | Y | Y | |
49884028352 | EVEROLIMUS | everolimus | TABLET | 1 mg | Y | Y | |
67877072131 | EVEROLIMUS | everolimus | TABLET | 1 mg | Y | Y | |
67877072133 | EVEROLIMUS | everolimus | TABLET | 1 mg | Y | Y | |
70377011211 | EVEROLIMUS | everolimus | TABLET | 1 mg | Y | Y | |
00078056751 | AFINITOR | everolimus | TABLET | 10 mg | Y | PA Document | |
00078056761 | AFINITOR | everolimus | TABLET | 10 mg | Y | PA Document | |
00054048213 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
00093776919 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
00093776924 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
49884012852 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
49884012891 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
51991082428 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
51991082433 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
51991082499 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
70377001311 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
70377001322 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
70377001323 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
72603025701 | EVEROLIMUS | everolimus | TABLET | 10 mg | Y | PA Document | |
00245082530 | TORPENZ | everolimus | TABLET | 10 mg | Y | PA Document | |
00078059451 | AFINITOR | everolimus | TABLET | 2.5 mg | Y | PA Document | |
00078059461 | AFINITOR | everolimus | TABLET | 2.5 mg | Y | PA Document | |
00054048013 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
00093776619 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
00093776624 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
49884011952 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
49884011991 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
51991082128 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
51991082133 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
51991082199 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
70377001011 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
70377001022 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
70377001023 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
72603025401 | EVEROLIMUS | everolimus | TABLET | 2.5 mg | Y | PA Document | |
00245082230 | TORPENZ | everolimus | TABLET | 2.5 mg | Y | PA Document | |
00078056651 | AFINITOR | everolimus | TABLET | 5 mg | Y | PA Document | |
00078056661 | AFINITOR | everolimus | TABLET | 5 mg | Y | PA Document | |
00054048113 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
00093776719 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
00093776724 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
49884012552 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
49884012591 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
51991082228 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
51991082233 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
51991082299 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
70377001111 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
70377001122 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
70377001123 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
72603025501 | EVEROLIMUS | everolimus | TABLET | 5 mg | Y | PA Document | |
00245082330 | TORPENZ | everolimus | TABLET | 5 mg | Y | PA Document | |
00078062051 | AFINITOR | everolimus | TABLET | 7.5 mg | Y | PA Document | |
00078062061 | AFINITOR | everolimus | TABLET | 7.5 mg | Y | PA Document | |
00054049713 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
00093776819 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
00093776824 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
49884012752 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
49884012791 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
51991082328 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
51991082333 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
51991082399 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
70377001211 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
70377001222 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
70377001223 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
72603025601 | EVEROLIMUS | everolimus | TABLET | 7.5 mg | Y | PA Document | |
00245082430 | TORPENZ | everolimus | TABLET | 7.5 mg | Y | PA Document | |
65597040601 | ENHERTU | fam-trastuzumab deruxtecn-nxki | VIAL | 100 mg | Y | PA Document | |
59572072012 | INREBIC | fedratinib dihydrochloride | CAPSULE | 100 mg | Y | PA Document | |
63020021021 | FRUZAQLA | fruquintinib | CAPSULE | 1 mg | Y | PA Document | |
63020022521 | FRUZAQLA | fruquintinib | CAPSULE | 5 mg | Y | PA Document | |
64842012004 | LYTGOBI | futibatinib | TABLET | 12 mg/day (4 mg x 3) | Y | PA Document | |
64842012021 | LYTGOBI | futibatinib | TABLET | 12 mg/day (4 mg x 3) | Y | PA Document | |
64842012005 | LYTGOBI | futibatinib | TABLET | 16 mg/day (4 mg x 4) | Y | PA Document | |
64842012028 | LYTGOBI | futibatinib | TABLET | 16 mg/day (4 mg x 4) | Y | PA Document | |
64842012006 | LYTGOBI | futibatinib | TABLET | 20 mg/day (4 mg x 5) | Y | PA Document | |
64842012035 | LYTGOBI | futibatinib | TABLET | 20 mg/day (4 mg x 5) | Y | PA Document | |
00469142590 | XOSPATA | gilteritinib fumarate | TABLET | 40 mg | Y | PA Document | |
00069153130 | DAURISMO | glasdegib maleate | TABLET | 100 mg | Y | PA Document | |
00069029860 | DAURISMO | glasdegib maleate | TABLET | 25 mg | Y | PA Document | |
50242012701 | COLUMVI | glofitamab-gxbm | VIAL | 10 mg/10 mL | Y | PA Document | |
50242012501 | COLUMVI | glofitamab-gxbm | VIAL | 2.5 mg/2.5 mL | Y | PA Document | |
57962014009 | IMBRUVICA | ibrutinib | CAPSULE | 140 mg | Y | PA Document | |
57962014012 | IMBRUVICA | ibrutinib | CAPSULE | 140 mg | Y | PA Document | |
57962007028 | IMBRUVICA | ibrutinib | CAPSULE | 70 mg | Y | PA Document | |
57962000712 | IMBRUVICA | ibrutinib | ORAL SUSP | 70 mg/mL | Y | PA Document | |
57962001428 | IMBRUVICA | ibrutinib | TABLET | 140 mg | Y | PA Document | |
57962028028 | IMBRUVICA | ibrutinib | TABLET | 280 mg | Y | PA Document | |
57962042028 | IMBRUVICA | ibrutinib | TABLET | 420 mg | Y | PA Document | |
59572051501 | ABECMA | idecabtagene vicleucel | PLAST. BAG | 300 x 10exp6 to 510 x 10exp6 cell | Y | PA Document | |
59572051502 | ABECMA | idecabtagene vicleucel | PLAST. BAG | 300 x 10exp6 to 510 x 10exp6 cell | Y | PA Document | |
59572051503 | ABECMA | idecabtagene vicleucel | PLAST. BAG | 300 x 10exp6 to 510 x 10exp6 cell | Y | PA Document | |
61958170101 | ZYDELIG | idelalisib | TABLET | 100 mg | Y | PA Document | |
61958170201 | ZYDELIG | idelalisib | TABLET | 150 mg | Y | PA Document | |
82959011101 | RYTELO | imetelstat sodium | VIAL | 188 mg | Y | PA Document | |
82959011201 | RYTELO | imetelstat sodium | VIAL | 47 mg | Y | PA Document | |
50242008408 | ITOVEBI | inavolisib | TABLET | 3 mg | Y | PA Document | |
50242007908 | ITOVEBI | inavolisib | TABLET | 9 mg | Y | PA Document | |
00008010001 | BESPONSA | inotuzumab ozogamicin | VIAL | 0.9 mg (0.25 mg/mL initial concentration) | Y | PA Document | |
00003232822 | YERVOY | ipilimumab | VIAL | 200 mg/40 mL (5 mg/mL) | Y | PA Document | |
00003232711 | YERVOY | ipilimumab | VIAL | 50 mg/10 mL (5 mg/mL) | Y | PA Document | |
00024065401 | SARCLISA | isatuximab-irfc | VIAL | 100 mg/5 mL (20 mg/mL) | Y | PA Document | |
00024065601 | SARCLISA | isatuximab-irfc | VIAL | 500 mg/25 mL | Y | PA Document | |
72694061760 | TIBSOVO | ivosidenib | TABLET | 250 mg | Y | PA Document | |
63020023001 | NINLARO | ixazomib citrate | CAPSULE | 2.3 mg | Y | PA Document | |
63020023002 | NINLARO | ixazomib citrate | CAPSULE | 2.3 mg | Y | PA Document | |
63020023003 | NINLARO | ixazomib citrate | CAPSULE | 2.3 mg | Y | PA Document | |
63020039001 | NINLARO | ixazomib citrate | CAPSULE | 3 mg | Y | PA Document | |
63020039002 | NINLARO | ixazomib citrate | CAPSULE | 3 mg | Y | PA Document | |
63020039003 | NINLARO | ixazomib citrate | CAPSULE | 3 mg | Y | PA Document | |
63020040001 | NINLARO | ixazomib citrate | CAPSULE | 4 mg | Y | PA Document | |
63020040002 | NINLARO | ixazomib citrate | CAPSULE | 4 mg | Y | PA Document | |
63020040003 | NINLARO | ixazomib citrate | CAPSULE | 4 mg | Y | PA Document | |
50419039101 | VITRAKVI | larotrectinib sulfate | CAPSULE | 100 mg | Y | PA Document | |
50419039001 | VITRAKVI | larotrectinib sulfate | CAPSULE | 25 mg | Y | PA Document | |
50419039201 | VITRAKVI | larotrectinib sulfate | SOLUTION | 20 mg/mL | Y | PA Document | |
50419039302 | VITRAKVI | larotrectinib sulfate | SOLUTION | 20 mg/mL | Y | PA Document | |
50419039303 | VITRAKVI | larotrectinib sulfate | SOLUTION | 20 mg/mL | Y | PA Document | |
57894024030 | LAZCLUZE | lazertinib mesylate | TABLET | 240 mg | Y | PA Document | |
57894008060 | LAZCLUZE | lazertinib mesylate | TABLET | 80 mg | Y | PA Document | |
62856071005 | LENVIMA | lenvatinib mesylate | CAPSULE | 10 mg/day (10 mg x 1) | Y | PA Document | |
62856071030 | LENVIMA | lenvatinib mesylate | CAPSULE | 10 mg/day (10 mg x 1) | Y | PA Document | |
62856071205 | LENVIMA | lenvatinib mesylate | CAPSULE | 12 mg/day (4 mg x 3) | Y | PA Document | |
62856071230 | LENVIMA | lenvatinib mesylate | CAPSULE | 12 mg/day (4 mg x 3) | Y | PA Document | |
62856071405 | LENVIMA | lenvatinib mesylate | CAPSULE | 14 mg/day (10 mg x 1 and 4 mg x 1) | Y | PA Document | |
62856071430 | LENVIMA | lenvatinib mesylate | CAPSULE | 14 mg/day (10 mg x 1 and 4 mg x 1) | Y | PA Document | |
62856071805 | LENVIMA | lenvatinib mesylate | CAPSULE | 18 mg/day (10 mg x 1 and 4 mg x 2) | Y | PA Document | |
62856071830 | LENVIMA | lenvatinib mesylate | CAPSULE | 18 mg/day (10 mg x 1 and 4 mg x 2) | Y | PA Document | |
62856072005 | LENVIMA | lenvatinib mesylate | CAPSULE | 20 mg/day (10 mg x 2) | Y | PA Document | |
62856072030 | LENVIMA | lenvatinib mesylate | CAPSULE | 20 mg/day (10 mg x 2) | Y | PA Document | |
62856072405 | LENVIMA | lenvatinib mesylate | CAPSULE | 24 mg per day (10 mg x 2 and 4 mg x 1) | Y | PA Document | |
62856072430 | LENVIMA | lenvatinib mesylate | CAPSULE | 24 mg per day (10 mg x 2 and 4 mg x 1) | Y | PA Document | |
62856070405 | LENVIMA | lenvatinib mesylate | CAPSULE | 4 mg | Y | PA Document | |
62856070430 | LENVIMA | lenvatinib mesylate | CAPSULE | 4 mg | Y | PA Document | |
62856070805 | LENVIMA | lenvatinib mesylate | CAPSULE | 8 mg/day (4 mg x 2) | Y | PA Document | |
62856070830 | LENVIMA | lenvatinib mesylate | CAPSULE | 8 mg/day (4 mg x 2) | Y | PA Document | |
61755005600 | LYNOZYFIC | linvoseltamab-gcpt | VIAL | 200 mg/10 mL (20 mg/mL) | Y | PA Document | |
61755005601 | LYNOZYFIC | linvoseltamab-gcpt | VIAL | 200 mg/10 mL (20 mg/mL) | Y | PA Document | |
61755005400 | LYNOZYFIC | linvoseltamab-gcpt | VIAL | 5 mg/2.5 mL (2 mg/mL) | Y | PA Document | |
61755005401 | LYNOZYFIC | linvoseltamab-gcpt | VIAL | 5 mg/2.5 mL (2 mg/mL) | Y | PA Document | |
73153090001 | BREYANZI | lisocabtagene maraleucel | VIAL | 1.5 x 10exp6 to 70 x 10exp6 cell/mL | Y | PA Document | |
73153090108 | BREYANZI CD8 COMPONENT | lisocabtagene maraleucel,1 of2 | VIAL | 1.5 x 10exp6 to 70 x 10exp6 cell/mL | Y | PA Document | |
73153090204 | BREYANZI CD4 COMPONENT | lisocabtagene maraleucel,2 of2 | VIAL | 1.5 x 10exp6 to 70 x 10exp6 cell/mL | Y | PA Document | |
79952011001 | ZYNLONTA | loncastuximab tesirine-lpyl | VIAL | 10 mg | Y | PA Document | |
00069023101 | LORBRENA | lorlatinib | TABLET | 100 mg | Y | PA Document | |
00069022701 | LORBRENA | lorlatinib | TABLET | 25 mg | Y | PA Document | |
00069022703 | LORBRENA | lorlatinib | TABLET | 25 mg | Y | PA Document | |
68727071201 | ZEPZELCA | lurbinectedin | VIAL | 4 mg | Y | PA Document | |
69488000301 | LUTATHERA | lutetium Lu 177 dotatate | VIAL | 10 mCi/mL (370 MBq/mL) | Y | PA Document | |
69488000370 | LUTATHERA | lutetium Lu 177 dotatate | VIAL | 10 mCi/mL (370 MBq/mL) | Y | PA Document | |
00078069802 | RYDAPT | midostaurin | CAPSULE | 25 mg | Y | PA Document | |
00078069819 | RYDAPT | midostaurin | CAPSULE | 25 mg | Y | PA Document | |
00078069851 | RYDAPT | midostaurin | CAPSULE | 25 mg | Y | PA Document | |
00078069899 | RYDAPT | midostaurin | CAPSULE | 25 mg | Y | PA Document | |
82448013042 | GOMEKLI | mirdametinib | CAPSULE | 1 mg | Y | PA Document | |
82448026042 | GOMEKLI | mirdametinib | CAPSULE | 2 mg | Y | PA Document | |
82448026084 | GOMEKLI | mirdametinib | CAPSULE | 2 mg | Y | PA Document | |
82448013442 | GOMEKLI | mirdametinib | TAB SUSP | 1 mg | Y | PA Document | |
82448013484 | GOMEKLI | mirdametinib | TAB SUSP | 1 mg | Y | PA Document | |
72903085301 | ELAHERE | mirvetuximab soravtansine-gynx | VIAL | 100 mg/20 mL (5 mg/mL) | Y | PA Document | |
42747076101 | POTELIGEO | mogamulizumab-kpkc | VIAL | 20 mg/5 mL (4 mg/mL) | Y | PA Document | |
81864010330 | OJJAARA | momelotinib dihydrochloride | TABLET | 100 mg | Y | PA Document | |
81864010230 | OJJAARA | momelotinib dihydrochloride | TABLET | 150 mg | Y | PA Document | |
81864010130 | OJJAARA | momelotinib dihydrochloride | TABLET | 200 mg | Y | PA Document | |
50242015901 | LUNSUMIO | mosunetuzumab-axgb | VIAL | 1 mg/mL | Y | PA Document | |
50242014201 | LUNSUMIO | mosunetuzumab-axgb | VIAL | 30 mg/30 mL (1 mg/mL) | Y | PA Document | |
55566105000 | ADSTILADRIN | nadofaragene firadenovec-vncg | VIAL | 3 x 10exp11 viral particles/mL | Y | PA Document | |
55566105001 | ADSTILADRIN | nadofaragene firadenovec-vncg | VIAL | 3 x 10exp11 viral particles/mL | Y | PA Document | |
73042020101 | DANYELZA | naxitamab-gqgk | VIAL | 40 mg/10 mL (4 mg/mL) | Y | PA Document | |
00002771601 | PORTRAZZA | necitumumab | VIAL | 800 mg/50 mL (16 mg/mL) | Y | PA Document | |
70437024018 | NERLYNX | neratinib maleate | TABLET | 40 mg | Y | PA Document | |
70437024033 | NERLYNX | neratinib maleate | TABLET | 40 mg | Y | PA Document | |
69097003117 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 150 mg | Y | PA Document | |
69097003156 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 150 mg | Y | PA Document | |
69097003174 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 150 mg | Y | PA Document | |
69097003217 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 200 mg | Y | PA Document | |
69097003256 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 200 mg | Y | PA Document | |
69097003274 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 200 mg | Y | PA Document | |
69097003008 | NILOTINIB TARTRATE | nilotinib tartrate | CAPSULE | 50 mg | Y | PA Document | |
24338015401 | DANZITEN | nilotinib tartrate | TABLET | 71 mg | Y | PA Document | |
24338015402 | DANZITEN | nilotinib tartrate | TABLET | 71 mg | Y | PA Document | |
24338015403 | DANZITEN | nilotinib tartrate | TABLET | 71 mg | Y | PA Document | |
24338015501 | DANZITEN | nilotinib tartrate | TABLET | 95 mg | Y | PA Document | |
24338015502 | DANZITEN | nilotinib tartrate | TABLET | 95 mg | Y | PA Document | |
24338015503 | DANZITEN | nilotinib tartrate | TABLET | 95 mg | Y | PA Document | |
69656010361 | ZEJULA | niraparib tosylate | CAPSULE | 100 mg | Y | PA Document | |
00173090913 | ZEJULA | niraparib tosylate | TABLET | 100 mg | Y | PA Document | |
00173091213 | ZEJULA | niraparib tosylate | TABLET | 200 mg | Y | PA Document | |
00173091261 | ZEJULA | niraparib tosylate | TABLET | 200 mg | Y | PA Document | |
00173091513 | ZEJULA | niraparib tosylate | TABLET | 300 mg | Y | PA Document | |
00173091561 | ZEJULA | niraparib tosylate | TABLET | 300 mg | Y | PA Document | |
57894010060 | AKEEGA | niraparib/abiraterone | TABLET | 100 mg-500 mg | Y | PA Document | |
57894005060 | AKEEGA | niraparib/abiraterone | TABLET | 50 mg-500 mg | Y | PA Document | |
82448010014 | OGSIVEO | nirogacestat hydrobromide | TABLET | 100 mg | Y | PA Document | |
82448015014 | OGSIVEO | nirogacestat hydrobromide | TABLET | 150 mg | Y | PA Document | |
82448005018 | OGSIVEO | nirogacestat hydrobromide | TABLET | 50 mg | Y | PA Document | |
00003377412 | OPDIVO | nivolumab | VIAL | 100 mg/10 mL | Y | PA Document | |
00003375614 | OPDIVO | nivolumab | VIAL | 120 mg/12 mL | Y | PA Document | |
00003373413 | OPDIVO | nivolumab | VIAL | 240 mg/24 mL | Y | PA Document | |
00003377211 | OPDIVO | nivolumab | VIAL | 40 mg/4 mL | Y | PA Document | |
00003612001 | OPDIVO QVANTIG | nivolumab-hyaluronidase-nvhy | VIAL | 600 mg-10,000 unit/5 mL | Y | PA Document | |
00003712511 | OPDUALAG | nivolumab-relatlimab-rmbw | VIAL | 240 mg-80 mg/20 mL | Y | PA Document | |
83047041004 | AUCATZYL | obecabtagene autoleucel | PLAST. BAG | Y | PA Document | ||
50242007001 | GAZYVA | obinutuzumab | VIAL | 1,000 mg/40 mL | Y | PA Document | |
00078069061 | ARZERRA | ofatumumab | VIAL | 1,000 mg/50 mL | Y | PA Document | |
00078066913 | ARZERRA | ofatumumab | VIAL | 100 mg/5 mL | Y | PA Document | |
00078066961 | ARZERRA | ofatumumab | VIAL | 100 mg/5 mL | Y | PA Document | |
00310056912 | LYNPARZA | olaparib | TABLET | 100 mg | Y | PA Document | |
00310056960 | LYNPARZA | olaparib | TABLET | 100 mg | Y | PA Document | |
00310066812 | LYNPARZA | olaparib | TABLET | 100 mg | Y | PA Document | |
00310066860 | LYNPARZA | olaparib | TABLET | 100 mg | Y | PA Document | |
00310057812 | LYNPARZA | olaparib | TABLET | 150 mg | Y | PA Document | |
00310057860 | LYNPARZA | olaparib | TABLET | 150 mg | Y | PA Document | |
00310067912 | LYNPARZA | olaparib | TABLET | 150 mg | Y | PA Document | |
00310067960 | LYNPARZA | olaparib | TABLET | 150 mg | Y | PA Document | |
71332000501 | REZLIDHIA | olutasidenib | CAPSULE | 150 mg | Y | PA Document | |
73441080004 | OMISIRGE | omidubicel-onlv | PLAST. BAG | Y | PA Document | ||
00310124830 | TAGRISSO | osimertinib mesylate | TABLET | 40 mg | Y | PA Document | |
00310134930 | TAGRISSO | osimertinib mesylate | TABLET | 40 mg | Y | PA Document | |
00310125130 | TAGRISSO | osimertinib mesylate | TABLET | 80 mg | Y | PA Document | |
00310135030 | TAGRISSO | osimertinib mesylate | TABLET | 80 mg | Y | PA Document | |
72482010012 | VONJO | pacritinib citrate | CAPSULE | 100 mg | Y | PA Document | |
00069018821 | IBRANCE | palbociclib | CAPSULE | 100 mg | Y | PA Document | |
00069018921 | IBRANCE | palbociclib | CAPSULE | 125 mg | Y | PA Document | |
00069018721 | IBRANCE | palbociclib | CAPSULE | 75 mg | Y | PA Document | |
00069048603 | IBRANCE | palbociclib | TABLET | 100 mg | Y | PA Document | |
00069048607 | IBRANCE | palbociclib | TABLET | 100 mg | Y | PA Document | |
00069068803 | IBRANCE | palbociclib | TABLET | 125 mg | Y | PA Document | |
00069068807 | IBRANCE | palbociclib | TABLET | 125 mg | Y | PA Document | |
00069028403 | IBRANCE | palbociclib | TABLET | 75 mg | Y | PA Document | |
00069028407 | IBRANCE | palbociclib | TABLET | 75 mg | Y | PA Document | |
00480418489 | PAZOPANIB HCL | pazopanib HCl | TABLET | 200 mg | Y | PA Document | |
59651058208 | PAZOPANIB HCL | pazopanib HCl | TABLET | 200 mg | Y | PA Document | |
60505477907 | PAZOPANIB HCL | pazopanib HCl | TABLET | 200 mg | Y | PA Document | |
63304011613 | PAZOPANIB HCL | pazopanib HCl | TABLET | 200 mg | Y | PA Document | |
82293002210 | PAZOPANIB HCL | pazopanib HCl | TABLET | 200 mg | Y | PA Document | |
00078107766 | VOTRIENT | pazopanib HCl | TABLET | 200 mg | Y | PA Document | |
00006302601 | KEYTRUDA | pembrolizumab | VIAL | 100 mg/4 mL (25 mg/mL) | Y | PA Document | |
00006302602 | KEYTRUDA | pembrolizumab | VIAL | 100 mg/4 mL (25 mg/mL) | Y | PA Document | |
00006302604 | KEYTRUDA | pembrolizumab | VIAL | 100 mg/4 mL (25 mg/mL) | Y | PA Document | |
00409106201 | PEMETREXED | pemetrexed | VIAL | 1 gram | Y | PA Document | |
00480451401 | PEMETREXED | pemetrexed | VIAL | 25 mg/mL | Y | PA Document | |
00480451501 | PEMETREXED | pemetrexed | VIAL | 25 mg/mL | Y | PA Document | |
00480451601 | PEMETREXED | pemetrexed | VIAL | 25 mg/mL | Y | PA Document | |
42367053133 | PEMFEXY | pemetrexed | VIAL | 25 mg/mL | Y | PA Document | |
83831013101 | AXTLE | pemetrexed dipotassium | VIAL | 100 mg | Y | PA Document | |
83831013201 | AXTLE | pemetrexed dipotassium | VIAL | 500 mg | Y | PA Document | |
50881002801 | PEMAZYRE | pemigatinib | TABLET | 13.5 mg | Y | PA Document | |
50881002601 | PEMAZYRE | pemigatinib | TABLET | 4.5 mg | Y | PA Document | |
50881002701 | PEMAZYRE | pemigatinib | TABLET | 9 mg | Y | PA Document | |
50242014501 | PERJETA | pertuzumab | VIAL | 420 mg/14 mL (30 mg/mL) | Y | PA Document | |
50242024501 | PHESGO | pertuzumab-trastuzumab-hy-zzxf | VIAL | 1,200 mg-600 mg-30,000 unit/15 mL | Y | PA Document | |
50242026001 | PHESGO | pertuzumab-trastuzumab-hy-zzxf | VIAL | 600 mg-600 mg-20,000 unit/10 mL | Y | PA Document | |
65597040720 | TURALIO | pexidartinib hydrochloride | CAPSULE | 125 mg | Y | PA Document | |
65597040728 | TURALIO | pexidartinib hydrochloride | CAPSULE | 125 mg | Y | PA Document | |
65597040228 | TURALIO | pexidartinib hydrochloride | CAPSULE | 200 mg | Y | PA Document | |
00002702660 | JAYPIRCA | pirtobrutinib | TABLET | 100 mg | Y | PA Document | |
00002690230 | JAYPIRCA | pirtobrutinib | TABLET | 50 mg | Y | PA Document | |
50242010501 | POLIVY | polatuzumab vedotin-piiq | VIAL | 140 mg | Y | PA Document | |
50242010301 | POLIVY | polatuzumab vedotin-piiq | VIAL | 30 mg | Y | PA Document | |
59572050100 | POMALYST | pomalidomide | CAPSULE | 1 mg | Y | PA Document | |
59572050121 | POMALYST | pomalidomide | CAPSULE | 1 mg | Y | PA Document | |
59572050200 | POMALYST | pomalidomide | CAPSULE | 2 mg | Y | PA Document | |
59572050221 | POMALYST | pomalidomide | CAPSULE | 2 mg | Y | PA Document | |
59572050300 | POMALYST | pomalidomide | CAPSULE | 3 mg | Y | PA Document | |
59572050321 | POMALYST | pomalidomide | CAPSULE | 3 mg | Y | PA Document | |
59572050400 | POMALYST | pomalidomide | CAPSULE | 4 mg | Y | PA Document | |
59572050421 | POMALYST | pomalidomide | CAPSULE | 4 mg | Y | PA Document | |
63020053630 | ICLUSIG | ponatinib HCl | TABLET | 10 mg | Y | PA Document | |
63020053530 | ICLUSIG | ponatinib HCl | TABLET | 15 mg | Y | PA Document | |
63020053330 | ICLUSIG | ponatinib HCl | TABLET | 30 mg | Y | PA Document | |
63020053430 | ICLUSIG | ponatinib HCl | TABLET | 45 mg | Y | PA Document | |
72893000301 | FOLOTYN | pralatrexate | VIAL | 20 mg/mL (1 mL) | Y | PA Document | |
65219055001 | PRALATREXATE | pralatrexate | VIAL | 20 mg/mL (1 mL) | Y | PA Document | |
72893000501 | FOLOTYN | pralatrexate | VIAL | 40 mg/2 mL (20 mg/mL) | Y | PA Document | |
65219055202 | PRALATREXATE | pralatrexate | VIAL | 40 mg/2 mL (20 mg/mL) | Y | PA Document | |
50242021060 | GAVRETO | pralsetinib | CAPSULE | 100 mg | Y | PA Document | |
50242021090 | GAVRETO | pralsetinib | CAPSULE | 100 mg | Y | PA Document | |
71332000660 | GAVRETO | pralsetinib | CAPSULE | 100 mg | Y | PA Document | |
71332000690 | GAVRETO | pralsetinib | CAPSULE | 100 mg | Y | PA Document | |
65597050404 | VANFLYTA | quizartinib dihydrochloride | TABLET | 17.7 mg | Y | PA Document | |
65597050428 | VANFLYTA | quizartinib dihydrochloride | TABLET | 17.7 mg | Y | PA Document | |
65597051104 | VANFLYTA | quizartinib dihydrochloride | TABLET | 26.5 mg | Y | PA Document | |
65597051128 | VANFLYTA | quizartinib dihydrochloride | TABLET | 26.5 mg | Y | PA Document | |
00002766901 | CYRAMZA | ramucirumab | VIAL | 100 mg/10 mL (10 mg/mL) | Y | PA Document | |
00002767801 | CYRAMZA | ramucirumab | VIAL | 500 mg/50 mL (10 mg/mL) | Y | PA Document | |
50419017101 | STIVARGA | regorafenib | TABLET | 40 mg | Y | PA Document | |
50419017103 | STIVARGA | regorafenib | TABLET | 40 mg | Y | PA Document | |
50419017105 | STIVARGA | regorafenib | TABLET | 40 mg | Y | PA Document | |
50419017106 | STIVARGA | regorafenib | TABLET | 40 mg | Y | PA Document | |
72974012001 | ORGOVYX | relugolix | TABLET | 120 mg | Y | PA Document | |
00003416014 | AUGTYRO | repotrectinib | CAPSULE | 160 mg | Y | PA Document | |
00003416060 | AUGTYRO | repotrectinib | CAPSULE | 160 mg | Y | PA Document | |
00003404060 | AUGTYRO | repotrectinib | CAPSULE | 40 mg | Y | PA Document | |
50881000603 | ZYNYZ | retifanlimab-dlwr | VIAL | 500 mg/20 mL | Y | PA Document | |
73555050100 | REVUFORJ | revumenib citrate | TABLET | 110 mg | Y | PA Document | |
73555050200 | REVUFORJ | revumenib citrate | TABLET | 160 mg | Y | PA Document | |
73555050000 | REVUFORJ | revumenib citrate | TABLET | 25 mg | Y | PA Document | |
00078086001 | KISQALI | ribociclib succinate | TABLET | 200 mg/day (200 mg x 1) | Y | PA Document | |
00078088821 | KISQALI | ribociclib succinate | TABLET | 200 mg/day (200 mg x 1) | Y | PA Document | |
00078086714 | KISQALI | ribociclib succinate | TABLET | 400 mg/day (200 mg x 2) | Y | PA Document | |
00078086742 | KISQALI | ribociclib succinate | TABLET | 400 mg/day (200 mg x 2) | Y | PA Document | |
00078089514 | KISQALI | ribociclib succinate | TABLET | 400 mg/day (200 mg x 2) | Y | PA Document | |
00078087421 | KISQALI | ribociclib succinate | TABLET | 600 mg/day (200 mg x 3) | Y | PA Document | |
00078087463 | KISQALI | ribociclib succinate | TABLET | 600 mg/day (200 mg x 3) | Y | PA Document | |
00078090221 | KISQALI | ribociclib succinate | TABLET | 600 mg/day (200 mg x 3) | Y | PA Document | |
00078090961 | KISQALI FEMARA CO-PACK | ribociclib succinate/letrozole | TABLET | 200 mg/day (200 mg x 1)-2.5 mg | Y | PA Document | |
00078091661 | KISQALI FEMARA CO-PACK | ribociclib succinate/letrozole | TABLET | 400 mg/day (200 mg x 2)-2.5 mg | Y | PA Document | |
00078092361 | KISQALI FEMARA CO-PACK | ribociclib succinate/letrozole | TABLET | 600 mg/day (200 mg x 3)-2.5 mg | Y | PA Document | |
73207010130 | QINLOCK | ripretinib | TABLET | 50 mg | Y | PA Document | |
59572096210 | ISTODAX | romidepsin | VIAL | 10 mg/2 mL | Y | PA Document | |
59572098401 | ISTODAX | romidepsin | VIAL | 10 mg/2 mL | Y | PA Document | |
63323092517 | ROMIDEPSIN | romidepsin | VIAL | 10 mg/2 mL | Y | PA Document | |
63323092688 | ROMIDEPSIN | romidepsin | VIAL | 10 mg/2 mL | Y | PA Document | |
00703400401 | ROMIDEPSIN | romidepsin | VIAL | 27.5 mg/5.5 mL (5 mg/mL) | Y | PA Document | |
73536050001 | BESREMI | ropeginterferon alfa-2b-njft | SYRINGE | 500 mcg/mL | Y | PA Document | |
69660020191 | RUBRACA | rucaparib camsylate | TABLET | 200 mg | Y | PA Document | |
82154078301 | RUBRACA | rucaparib camsylate | TABLET | 200 mg | Y | PA Document | |
69660020291 | RUBRACA | rucaparib camsylate | TABLET | 250 mg | Y | PA Document | |
82154078401 | RUBRACA | rucaparib camsylate | TABLET | 250 mg | Y | PA Document | |
69660020391 | RUBRACA | rucaparib camsylate | TABLET | 300 mg | Y | PA Document | |
82154078501 | RUBRACA | rucaparib camsylate | TABLET | 300 mg | Y | PA Document | |
50881001060 | JAKAFI | ruxolitinib phosphate | TABLET | 10 mg | Y | PA Document | |
50881001560 | JAKAFI | ruxolitinib phosphate | TABLET | 15 mg | Y | PA Document | |
50881002060 | JAKAFI | ruxolitinib phosphate | TABLET | 20 mg | Y | PA Document | |
50881002560 | JAKAFI | ruxolitinib phosphate | TABLET | 25 mg | Y | PA Document | |
50881000560 | JAKAFI | ruxolitinib phosphate | TABLET | 5 mg | Y | PA Document | |
55135013201 | TRODELVY | sacituzumab govitecan-hziy | VIAL | 180 mg | Y | PA Document | |
72237010305 | XPOVIO | selinexor | TABLET | 100 mg/week (50 mg x 2) | Y | PA Document | |
72237010315 | XPOVIO | selinexor | TABLET | 100 mg/week (50 mg x 2) | Y | PA Document | |
72237010206 | XPOVIO | selinexor | TABLET | 40 mg twice weekly (80 mg/week) (40 mg x 2) | Y | PA Document | |
72237010216 | XPOVIO | selinexor | TABLET | 40 mg twice weekly (80 mg/week) (40 mg x 2) | Y | PA Document | |
72237010601 | XPOVIO | selinexor | TABLET | 40 mg/week (10 mg x 4) | Y | PA Document | |
72237010611 | XPOVIO | selinexor | TABLET | 40 mg/week (10 mg x 4) | Y | PA Document | |
72237010207 | XPOVIO | selinexor | TABLET | 40 mg/week (40 mg x 1) | Y | PA Document | |
72237010217 | XPOVIO | selinexor | TABLET | 40 mg/week (40 mg x 1) | Y | PA Document | |
72237010103 | XPOVIO | selinexor | TABLET | 60 mg twice weekly (120 mg/week) (20 mg x 6) | Y | PA Document | |
72237010113 | XPOVIO | selinexor | TABLET | 60 mg twice weekly (120 mg/week) (20 mg x 6) | Y | PA Document | |
72237010401 | XPOVIO | selinexor | TABLET | 60 mg/week (60 mg x 1) | Y | PA Document | |
72237010411 | XPOVIO | selinexor | TABLET | 60 mg/week (60 mg x 1) | Y | PA Document | |
72237010104 | XPOVIO | selinexor | TABLET | 80 mg twice weekly (160 mg/week) (20 mg x 8) | Y | PA Document | |
72237010114 | XPOVIO | selinexor | TABLET | 80 mg twice weekly (160 mg/week) (20 mg x 8) | Y | PA Document | |
72237010202 | XPOVIO | selinexor | TABLET | 80 mg/week (40 mg x 2) | Y | PA Document | |
72237010212 | XPOVIO | selinexor | TABLET | 80 mg/week (40 mg x 2) | Y | PA Document | |
00002397760 | RETEVMO | selpercatinib | CAPSULE | 40 mg | Y | PA Document | |
00002298026 | RETEVMO | selpercatinib | CAPSULE | 80 mg | Y | PA Document | |
00002298060 | RETEVMO | selpercatinib | CAPSULE | 80 mg | Y | PA Document | |
00002612060 | RETEVMO | selpercatinib | TABLET | 120 mg | Y | PA Document | |
00002556260 | RETEVMO | selpercatinib | TABLET | 160 mg | Y | PA Document | |
00002534060 | RETEVMO | selpercatinib | TABLET | 40 mg | Y | PA Document | |
00002608260 | RETEVMO | selpercatinib | TABLET | 80 mg | Y | PA Document | |
00310061028 | KOSELUGO | selumetinib sulfate | CAPSULE | 10 mg | Y | PA Document | |
00310061060 | KOSELUGO | selumetinib sulfate | CAPSULE | 10 mg | Y | PA Document | |
00310062528 | KOSELUGO | selumetinib sulfate | CAPSULE | 25 mg | Y | PA Document | |
00310062560 | KOSELUGO | selumetinib sulfate | CAPSULE | 25 mg | Y | PA Document | |
73090042001 | SYLVANT | siltuximab | VIAL | 100 mg | Y | PA Document | |
73090042101 | SYLVANT | siltuximab | VIAL | 400 mg | Y | PA Document | |
30237890005 | PROVENGE | sipuleucel-T/lactated ringers | PLAST. BAG | 50 million cell/250 mL | Y | PA Document | |
30237890006 | PROVENGE | sipuleucel-T/lactated ringers | PLAST. BAG | 50 million cell/250 mL | Y | PA Document | |
80803015350 | FYARRO | sirolimus protein-bound | VIAL | 100 mg | Y | PA Document | |
47335030383 | ODOMZO | sonidegib phosphate | CAPSULE | 200 mg | Y | PA Document | |
55513048824 | LUMAKRAS | sotorasib | TABLET | 120 mg | Y | PA Document | |
55513048840 | LUMAKRAS | sotorasib | TABLET | 120 mg | Y | PA Document | |
55513048896 | LUMAKRAS | sotorasib | TABLET | 120 mg | Y | PA Document | |
55513051260 | LUMAKRAS | sotorasib | TABLET | 240 mg | Y | PA Document | |
55513050450 | LUMAKRAS | sotorasib | TABLET | 320 mg | Y | PA Document | |
50881001303 | MONJUVI | tafasitamab-cxix | VIAL | 200 mg | Y | PA Document | |
73535020801 | MONJUVI | tafasitamab-cxix | VIAL | 200 mg | Y | PA Document | |
72187040101 | ELZONRIS | tagraxofusp-erzs | VIAL | 1,000 mcg/mL | Y | PA Document | |
00069025230 | TALZENNA | talazoparib tosylate | CAPSULE | 0.1 mg | Y | PA Document | |
00069103130 | TALZENNA | talazoparib tosylate | CAPSULE | 0.1 mg | Y | PA Document | |
00069029630 | TALZENNA | talazoparib tosylate | CAPSULE | 0.25 mg | Y | PA Document | |
00069035330 | TALZENNA | talazoparib tosylate | CAPSULE | 0.25 mg | Y | PA Document | |
00069045430 | TALZENNA | talazoparib tosylate | CAPSULE | 0.35 mg | Y | PA Document | |
00069123530 | TALZENNA | talazoparib tosylate | CAPSULE | 0.35 mg | Y | PA Document | |
00069054630 | TALZENNA | talazoparib tosylate | CAPSULE | 0.5 mg | Y | PA Document | |
00069150130 | TALZENNA | talazoparib tosylate | CAPSULE | 0.5 mg | Y | PA Document | |
00069065530 | TALZENNA | talazoparib tosylate | CAPSULE | 0.75 mg | Y | PA Document | |
00069175130 | TALZENNA | talazoparib tosylate | CAPSULE | 0.75 mg | Y | PA Document | |
00069075730 | TALZENNA | talazoparib tosylate | CAPSULE | 1 mg | Y | PA Document | |
00069119530 | TALZENNA | talazoparib tosylate | CAPSULE | 1 mg | Y | PA Document | |
84651020030 | IBTROZI | taletrectinib adipate | CAPSULE | 200 mg | Y | PA Document | |
84651020093 | IBTROZI | taletrectinib adipate | CAPSULE | 200 mg | Y | PA Document | |
55513007801 | IMLYGIC | talimogene laherparepvec | VIAL | 10exp6 (1 million) PFU/mL | Y | PA Document | |
55513007901 | IMLYGIC | talimogene laherparepvec | VIAL | 10exp8 (100 million) PFU/mL | Y | PA Document | |
57894046901 | TALVEY | talquetamab-tgvs | VIAL | 3 mg/1.5 mL (2 mg/mL) | Y | PA Document | |
57894047001 | TALVEY | talquetamab-tgvs | VIAL | 40 mg/mL | Y | PA Document | |
55513005901 | IMDELLTRA | tarlatamab-dlle | VIAL | 1 mg | Y | PA Document | |
55513010301 | IMDELLTRA | tarlatamab-dlle | VIAL | 1 mg | Y | PA Document | |
55513006901 | IMDELLTRA | tarlatamab-dlle | VIAL | 10 mg | Y | PA Document | |
55513007701 | IMDELLTRA | tarlatamab-dlle | VIAL | 10 mg | Y | PA Document | |
72607010000 | TAZVERIK | tazemetostat hydrobromide | TABLET | 200 mg | Y | PA Document | |
80446040101 | KIMMTRAK | tebentafusp-tebn | VIAL | 100 mcg/0.5 mL | Y | PA Document | |
57894045001 | TECVAYLI | teclistamab-cqyv | VIAL | 153 mg/1.7 mL (90 mg/mL) | Y | PA Document | |
57894044901 | TECVAYLI | teclistamab-cqyv | VIAL | 30 mg/3 mL (10 mg/mL) | Y | PA Document | |
00074105501 | EMRELIS | telisotuzumab vedotin-tllv | VIAL | 100 mg | Y | PA Document | |
00074104401 | EMRELIS | telisotuzumab vedotin-tllv | VIAL | 20 mg | Y | PA Document | |
44087500003 | TEPMETKO | tepotinib HCl | TABLET | 225 mg | Y | PA Document | |
44087500006 | TEPMETKO | tepotinib HCl | TABLET | 225 mg | Y | PA Document | |
00078084619 | KYMRIAH | tisagenlecleucel | PLAST. BAG | 0.2 x 10exp6 to 2.5 x 10exp8 cell | Y | PA Document | |
00078095819 | KYMRIAH | tisagenlecleucel | PLAST. BAG | 0.6 x 10exp8 to 6 x 10exp8 cell | Y | PA Document | |
72579012101 | TEVIMBRA | tislelizumab-jsgr | VIAL | 100 mg/10 mL (10 mg/mL) | Y | PA Document | |
51144000301 | TIVDAK | tisotumab vedotin-tftv | VIAL | 40 mg | Y | PA Document | |
45629008901 | FOTIVDA | tivozanib HCl | CAPSULE | 0.89 mg | Y | PA Document | |
45629013401 | FOTIVDA | tivozanib HCl | CAPSULE | 1.34 mg | Y | PA Document | |
70114034001 | LOQTORZI | toripalimab-tpzi | VIAL | 240 mg/6 mL (40 mg/mL) | Y | PA Document | |
82950001201 | OJEMDA | tovorafenib | SUSP RECON | 25 mg/mL | Y | PA Document | |
82950011210 | OJEMDA | tovorafenib | SUSP RECON | 25 mg/mL | Y | PA Document | |
82950000116 | OJEMDA | tovorafenib | TABLET | 400 mg/week (100 mg x 4) | Y | PA Document | |
82950000120 | OJEMDA | tovorafenib | TABLET | 500 mg/week (100 mg x 5) | Y | PA Document | |
82950000124 | OJEMDA | tovorafenib | TABLET | 600 mg/week (100 mg x 6) | Y | PA Document | |
59676061001 | YONDELIS | trabectedin | VIAL | 1 mg | Y | PA Document | |
00078116147 | MEKINIST | trametinib dimethyl sulfoxide | SOLN RECON | 0.05 mg/mL | Y | PA Document | |
00078110515 | MEKINIST | trametinib dimethyl sulfoxide | TABLET | 0.5 mg | Y | PA Document | |
00078111215 | MEKINIST | trametinib dimethyl sulfoxide | TABLET | 2 mg | Y | PA Document | |
55513014101 | KANJINTI | trastuzumab-anns | VIAL | 150 mg | Y | PA Document | |
55513013201 | KANJINTI | trastuzumab-anns | VIAL | 420 mg | Y | PA Document | |
67457099115 | OGIVRI | trastuzumab-dkst | VIAL | 150 mg | Y | PA Document | |
83257000111 | OGIVRI | trastuzumab-dkst | VIAL | 150 mg | Y | PA Document | |
67457084550 | OGIVRI | trastuzumab-dkst | VIAL | 420 mg | Y | PA Document | |
67457084744 | OGIVRI | trastuzumab-dkst | VIAL | 420 mg | Y | PA Document | |
83257000311 | OGIVRI | trastuzumab-dkst | VIAL | 420 mg | Y | PA Document | |
83257000412 | OGIVRI | trastuzumab-dkst | VIAL | 420 mg | Y | PA Document | |
78206014701 | ONTRUZANT | trastuzumab-dttb | VIAL | 150 mg | Y | PA Document | |
78206014799 | ONTRUZANT | trastuzumab-dttb | VIAL | 150 mg | Y | PA Document | |
78206014801 | ONTRUZANT | trastuzumab-dttb | VIAL | 420 mg | Y | PA Document | |
78206014899 | ONTRUZANT | trastuzumab-dttb | VIAL | 420 mg | Y | PA Document | |
50242007701 | HERCEPTIN HYLECTA | trastuzumab-hyaluronidase-oysk | VIAL | 600 mg-10,000 unit/5 mL | Y | PA Document | |
63459030343 | HERZUMA | trastuzumab-pkrb | VIAL | 150 mg | Y | PA Document | |
63459030547 | HERZUMA | trastuzumab-pkrb | VIAL | 420 mg | Y | PA Document | |
63459030741 | HERZUMA | trastuzumab-pkrb | VIAL | 420 mg | Y | PA Document | |
00069030801 | TRAZIMERA | trastuzumab-qyyp | VIAL | 150 mg | Y | PA Document | |
00069030501 | TRAZIMERA | trastuzumab-qyyp | VIAL | 420 mg | Y | PA Document | |
00069030601 | TRAZIMERA | trastuzumab-qyyp | VIAL | 420 mg | Y | PA Document | |
69448001505 | HERCESSI | trastuzumab-strf | VIAL | 150 mg | Y | PA Document | |
69448001611 | HERCESSI | trastuzumab-strf | VIAL | 420 mg | Y | PA Document | |
00310450525 | IMJUDO | tremelimumab-actl | VIAL | 25 mg/1.25 mL (20 mg/mL) | Y | PA Document | |
00310453530 | IMJUDO | tremelimumab-actl | VIAL | 300 mg/15 mL (20 mg/mL) | Y | PA Document | |
59137033500 | GRAFAPEX | treosulfan | VIAL | 1 gram | Y | PA Document | |
59137033501 | GRAFAPEX | treosulfan | VIAL | 1 gram | Y | PA Document | |
59137036500 | GRAFAPEX | treosulfan | VIAL | 5 gram | Y | PA Document | |
59137036501 | GRAFAPEX | treosulfan | VIAL | 5 gram | Y | PA Document | |
64842102501 | LONSURF | trifluridine/tipiracil HCl | TABLET | 15 mg-6.14 mg | Y | PA Document | |
64842102502 | LONSURF | trifluridine/tipiracil HCl | TABLET | 15 mg-6.14 mg | Y | PA Document | |
64842102503 | LONSURF | trifluridine/tipiracil HCl | TABLET | 15 mg-6.14 mg | Y | PA Document | |
64842102001 | LONSURF | trifluridine/tipiracil HCl | TABLET | 20 mg-8.19 mg | Y | PA Document | |
64842102002 | LONSURF | trifluridine/tipiracil HCl | TABLET | 20 mg-8.19 mg | Y | PA Document | |
64842102003 | LONSURF | trifluridine/tipiracil HCl | TABLET | 20 mg-8.19 mg | Y | PA Document | |
51144000212 | TUKYSA | tucatinib | TABLET | 150 mg | Y | PA Document | |
51144000260 | TUKYSA | tucatinib | TABLET | 150 mg | Y | PA Document | |
51144000160 | TUKYSA | tucatinib | TABLET | 50 mg | Y | PA Document | |
58468782003 | CAPRELSA | vandetanib | TABLET | 100 mg | Y | PA Document | |
58468784003 | CAPRELSA | vandetanib | TABLET | 300 mg | Y | PA Document | |
50242009002 | ZELBORAF | vemurafenib | TABLET | 240 mg | Y | PA Document | |
00074057928 | VENCLEXTA STARTING PACK | venetoclax | TAB DS PK | 10 mg (14)-50 mg (7)-100 mg (21) | Y | PA Document | |
00074056111 | VENCLEXTA | venetoclax | TABLET | 10 mg | Y | PA Document | |
00074056114 | VENCLEXTA | venetoclax | TABLET | 10 mg | Y | PA Document | |
00074057611 | VENCLEXTA | venetoclax | TABLET | 100 mg | Y | PA Document | |
00074057622 | VENCLEXTA | venetoclax | TABLET | 100 mg | Y | PA Document | |
00074057630 | VENCLEXTA | venetoclax | TABLET | 100 mg | Y | PA Document | |
00074056607 | VENCLEXTA | venetoclax | TABLET | 50 mg | Y | PA Document | |
00074056611 | VENCLEXTA | venetoclax | TABLET | 50 mg | Y | PA Document | |
73207030240 | ROMVIMZA | vimseltinib | CAPSULE | 14 mg | Y | PA Document | |
73207030340 | ROMVIMZA | vimseltinib | CAPSULE | 20 mg | Y | PA Document | |
73207030440 | ROMVIMZA | vimseltinib | CAPSULE | 30 mg | Y | PA Document | |
50242014001 | ERIVEDGE | vismodegib | CAPSULE | 150 mg | Y | PA Document | |
72694087910 | VORANIGO | vorasidenib citrate | TABLET | 10 mg | Y | PA Document | |
72694072840 | VORANIGO | vorasidenib citrate | TABLET | 40 mg | Y | PA Document | |
68727095001 | ZIIHERA | zanidatamab-hrii | VIAL | 300 mg | Y | PA Document | |
68727095002 | ZIIHERA | zanidatamab-hrii | VIAL | 300 mg | Y | PA Document | |
72579001102 | BRUKINSA | zanubrutinib | CAPSULE | 80 mg | Y | PA Document | |
72579012201 | BRUKINSA | zanubrutinib | TABLET | 160 mg | Y | PA Document | |
71837100001 | BIZENGRI | zenocutuzumab-zbco | VIAL | 375 mg/18.75 mL (20 mg/mL) | Y | PA Document | |
71837100002 | BIZENGRI | zenocutuzumab-zbco | VIAL | 375 mg/18.75 mL (20 mg/mL) | Y | PA Document | |
00024584001 | ZALTRAP | ziv-aflibercept | VIAL | 100 mg/4 mL (25 mg/mL) | Y | PA Document | |
00024584101 | ZALTRAP | ziv-aflibercept | VIAL | 200 mg/8 mL (25 mg/mL) | Y | PA Document | |
00469342510 | VYLOY | zolbetuximab-clzb | VIAL | 100 mg | Y | PA Document | |
00469442530 | VYLOY | zolbetuximab-clzb | VIAL | 300 mg | Y | PA Document | |
00597925786 | HERNEXEOS | zongertinib | TABLET | 60 mg | Y | PA Document |